{
    "title": "Australia's CSL in mRNA vaccine licensing deal with U.S.-based Arcturus",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11379537/Australias-CSL-mRNA-vaccine-licensing-deal-U-S-based-Arcturus.html",
    "date": "2022-11-01",
    "keywords": [
        "vaccine",
        "arcturus",
        "technology",
        "csl",
        "generation",
        "mrna",
        "covid19",
        "ltd",
        "wednesday",
        "licensing",
        "deal",
        "inc",
        "access",
        "drug",
        "firm",
        "upfront",
        "return",
        "licence",
        "influenza",
        "statement",
        "development",
        "net",
        "profit",
        "share",
        "company",
        "preparedness",
        "respiratory",
        "collaboration",
        "opportunity",
        "program",
        "partner",
        "platform",
        "stage",
        "scale",
        "chief",
        "officer",
        "paul",
        "mckenzie",
        "april",
        "covid",
        "disease",
        "august",
        "booster",
        "omicron",
        "pfizer",
        "market",
        "dominance",
        "business",
        "time",
        "blood",
        "plasma",
        "reporting",
        "singh",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}